JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
$234.88
-5.69 (-2.37%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+81.25%
YTD
+35.65%
Open$239.26
Previous Close$240.57
Day High$241.33
Day Low$231.59
52W High$266.38
52W Low$125.79
Volume—
Avg Volume551.4K
Market Cap15.83B
P/E Ratio16.83
EPS$14.63
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$167.39
Above
SMA 200
$136.05
Above
RSI (14)
68.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-20.7% upside
Current
$234.88
$234.88
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.60B | 4.37B | 1.73B |
| Net Income | -384,002,539 | -328,332,020 | 500.28M |
| Profit Margin | -8.4% | -7.9% | 28.9% |
| EBITDA | 241.97M | 218.39M | 730.31M |
| Free Cash Flow | — | — | 376.40M |
| Rev Growth | +5.3% | +5.3% | +7.8% |
| Debt/Equity | 1.24 | 1.24 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.46 | +3.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $271.59 | +0.90% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.83 | +0.51% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.45 | +0.96% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $70.27 | -1.87% | 11.5 | 30.15B |